# Editorial: Trends in neurocritical care

**Authors:** Po-Huang Chen, Hong-Jie Jhou, Cho-Hao Lee, Shey-Lin Wu

PMC · DOI: 10.3389/fneur.2024.1403510 · 2024-05-01

## Full-text entities

- **Diseases:** thyrotoxicosis (MESH:C566386), hyperglycemia (MESH:D006943), SAH (MESH:D013345), Chorea (MESH:D002819), ischemic stroke (MESH:D002544), critically ill (MESH:D016638), Graves' disease (MESH:D006111), Moyamoya (MESH:D009072), neurocritical illnesses (MESH:D002908), death (MESH:D003643), inflammation (MESH:D007249), ischemic changes in the brain (MESH:D020520), hypertension (MESH:D006973), hypernatremia (MESH:D006955), thyroid (MESH:D013966), stroke (MESH:D020521), neurological emergencies (MESH:D004630), movement disorder (MESH:D009069), neurological and systemic diseases (MESH:D009422), diabetes (MESH:D003920), atrial fibrillation (MESH:D001281), hyperkinetic movements (MESH:D006948)
- **Chemicals:** sodium (MESH:D012964), dexamethasone (MESH:D003907), steroid (MESH:D013256)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** H — Rattus norvegicus (Rat), Adenocarcinoma of the rat prostate, Cancer cell line (CVCL_Y658)

---
Source: https://tomesphere.com/paper/PMC11094332